Page 146 - 南京医科大学自然版

第45卷第11期
·1676 · 南 京 医 科 大 学 学 报 2025年11月

Alzheimer disease vs other neurodegenerative disorders in the European population，inspiration from amyloid beta
［J］. JAMA，2020，324（8）：772-781 and tau protein［J］. Heliyon，2024，10（20）：e39013
［16］PARK S A，AN Y S，PARK Y J，et al. Comparative analy⁃ ［27］HAMPEL H，CUMMINGS J，BLENNOW K，et al. Deve⁃
sis of Elecsys and ELISA for differentiating amyloid⁃PET loping the ATX（N）classification for use across the
status in a Korean memory clinic based on cerebrospinal Alzheimer disease continuum［J］. Nat Rev Neurol，2021，
fluid biomarkers［J］. J Alzheimers Dis，2025，104（1）： 17（9）：580-589
232-244 ［28］ HEY J A，YU J Y，ABUSHAKRA S，et al. Analysis of
［17］MUSSO G，GABELLI C，PUTHENPARAMPIL M，et al. cerebrospinal fluid，plasma β ⁃ amyloid biomarkers，and
Blood biomarkers for Alzheimer’s disease with the lumi⁃ cognition from a 2⁃year phase 2 trial evaluating oral ALZ⁃
pulse automated platform：age ⁃ effect and clinical value 801/valiltramiprosate in APOE4 carriers with early Al⁃
interpretation［J］. Clin Chim Acta，2025，565：120014 zheimer’s disease using quantitative systems pharmacolo⁃
［18］ HONIG L S，KANG M S，LEE A J，et al. Evaluation of gy model［J］. Drugs，2024，84（7）：825-839
plasma biomarkers for A/T/N classification of Alzheimer ［29］CHEN X Y，WAN S F，YAO N N，et al. Inhibition of the
disease among adults of Caribbean hispanic ethnicity［J］. immunoproteasome LMP2 ameliorates ischemia/hypoxia ⁃
JAMA Netw Open，2023，6（4）：e238214 induced blood ⁃ brain barrier injury through the Wnt/β ⁃
［19］ MILÀ ⁃ ALOMÀ M，ASHTON N J，SHEKARI M，et al. catenin signalling pathway［J］. Mil Med Res，2021，8（1）：62
Plasma p⁃tau231 and p⁃tau217 as state markers of amyloid⁃ ［30］ BERNOCCHI F，BONOMI C G，ASSOGNA M，et al.
β pathology in preclinical Alzheimer’s disease［J］. Nat Astrocytic⁃derived vascular remodeling factors are inde⁃
Med，2022，28（9）：1797-1801 pendently associated with blood brain barrier permeability
［20］ASHTON N J，JANELIDZE S，MATTSSON⁃CARLGREN in Alzheimer’s disease［J］. Neurobiol Aging，2024，141：
N，et al. Differential roles of A β42/40，p⁃tau231 and 66-73
p ⁃ tau217 for Alzheimer’s trial selection and disease ［31］SMYTH L C D，HIGHET B，JANSSON D，et al. Characte⁃
monitoring［J］. Nat Med，2022，28（12）：2555-2562 risation of PDGF⁃BB：PDGFRβ signalling pathways in
［21］KARAMIAN A，FARZANEH H，KHOSHNOODI M，et al. human brain pericytes：evidence of disruption in Alzhei⁃
Accuracy of GFAP and UCH ⁃ L1 in predicting brain mer’s disease［J］. Commun Biol，2022，5（1）：235
abnormalities on CT scans after mild traumatic brain injury： ［32］VERMA A，SHTEINFER⁃KUZMINE A，KAMENETSKY
a systematic review and meta⁃analysis［J］. Eur J Trauma N，et al. Targeting the overexpressed mitochondrial
Emerg Surg，2025，51（1）：68 protein VDAC1 in a mouse model of Alzheimer’s disease
［22］ ASHTON N J，PASCOAL T A，KARIKARI T K，et al. protects against mitochondrial dysfunction and mitigates
Plasma p⁃tau231：a new biomarker for incipient Alzhei⁃ brain pathology［J］. Transl Neurodegener，2022，11（1）：58
mer’s disease pathology［J］. Acta Neuropathol，2021，141 ［33］NI X C，WANG H F，CAI Y Y，et al. Ginsenoside Rb1
（5）：709-724 inhibits astrocyte activation and promotes transfer of astro⁃
［23］ELAHI F M，CASALETTO K B，JOIE R L，et al. Plasma cytic mitochondria to neurons against ischemic stroke［J］.
biomarkers of astrocytic and neuronal dysfunction in early⁃ Redox Biol，2022，54：102363
and late ⁃ onset Alzheimer’s disease［J］. Alzheimers ［34］CAI J，CHEN Y，SHE Y，et al. Aerobic exercise improves
Dement，2020，16（4）：681-695 astrocyte mitochondrial quality and transfer to neurons in
［24］ VERBERK I M W，THIJSSEN E，KOELEWIJN J，et al. a mouse model of Alzheimer’s disease［J］. Brain Pathol，
Combination of plasma amyloid beta（1 ⁃ 42/1 ⁃ 40）and 2025，35（3）：e13316
glial fibrillary acidic protein strongly associates with ［35］ 孟清琳，潘 娜，刘养凤，等. CTCFL/RPS3A 通过抑制
cerebral amyloid pathology［J］. Alzheimers Res Ther， 内质网应激减少神经元细胞凋亡缓解阿尔兹海默症
2020，12（1）：118 大鼠认知功能障碍实验研究［J］. 陕西医学杂志，
［25］CICOGNOLA C，JANELIDZE S，HERTZE J，et al. Plasma 2024，53（10）：1314-1319
glial fibrillary acidic protein detects Alzheimer pathology MENG Q L，PAN N，LIU Y F，et al. CTCFL/RPS3A
and predicts future conversion to Alzheimer dementia in reduces neuronal apoptosis and alleviates cognitive
patients with mild cognitive impairment［J］. Alzheimers dysfunction in Alzheimer’s disease rats by inhibiting ER
Res Ther，2021，13（1）：68 stress［J］. Shaanxi Medical Journal，2024，53（10）：
［26］WANG X F，YANG H Y，ZHAN D C，et al. Novel targets 1314-1319
for the treatment and prevention of Alzheimer’s disease ［36］ DU X Q，WANG H Q，LIU S Y，et al. Astrocytic GluN2A